Home / Biotechnology

Global Organ-On-Chip (OOCs) Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19563635 | Published Date: 18-Nov-2021 | No. of pages: 97

Description

The Organ-On-Chip (OOCs) market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Organ-On-Chip (OOCs) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Organ-On-Chip (OOCs) Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Organ-On-Chip (OOCs) market are:
BiomimX SRL
Tara Biosystems
Emulate Inc.
Elveflow
TissUse GmbH
Mimetas BV
Hurel Corporation
Micronit
Kirkstall
Nortis Inc.

Most important types of Organ-On-Chip (OOCs) products covered in this report are:
Lung-On-Chip
Multi-Organs On Chip
Heart-On-Chip
Liver-On-Chip
Intestine-On-Chip
Kidney-On-Chip
Skin-On-Chip
Blood-Brain-Barrier-On-Chip
Other Organ Models

Most widely used downstream fields of Organ-On-Chip (OOCs) market covered in this report are:
Toxicology Research
Drug Discovery
Molecular Biology
Disease Modelling
Food Safety
Other Applications

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.